METHODS AND COMPOSITIONS USING DEHYDRATED HUMAN AMNION/CHORION MEMBRANE ALLOGRAFT AND AMNIONIC MEMBRANE ALLOGRAFT SUSPENSIONS FOR THE TREATMENT OF HAIR LOSS
First Claim
1. A composition comprising, (a) and one or more of (b) and (c) as active ingredients in therapeutic amounts effective to promote hair growth of a subject:
- (a) platelet rich plasma (“
PRP”
)(b) dehydrated human amnion/chorion membrane allograft (“
dHACM”
);
(c) amnionic membrane allograft suspension (“
AMA”
);
wherein said therapeutic amounts of (b) or (c) when present is in the range of 25 mg to 100 mg.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to compositions and methods for the treatment of hair loss and for promoting hair growth by subcutaneously or intradermally administering injections of compositions comprising therapeutically-effective amounts of extracts of one or more dehydrated human amnion/chorion membrane allografts (“dHACM”) and/or amnionic membrane allografts (“AMA”) suspensions, alone or in combination with one or more extracts of platelet rich plasma (“PRP”), wherein the dHACM and/or AMA suspensions are administered in therapeutic dosages and in a composition for use in the disclosed method.
0 Citations
7 Claims
-
1. A composition comprising, (a) and one or more of (b) and (c) as active ingredients in therapeutic amounts effective to promote hair growth of a subject:
-
(a) platelet rich plasma (“
PRP”
)(b) dehydrated human amnion/chorion membrane allograft (“
dHACM”
);(c) amnionic membrane allograft suspension (“
AMA”
);wherein said therapeutic amounts of (b) or (c) when present is in the range of 25 mg to 100 mg. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A kit comprising:
-
a first container containing a therapeutic amount of dehydrated human amnion/chorion membrane allograft (“
dHACM”
) and/or amnionic membrane allograft suspension (“
AMA”
); anda second container for the collection of platelet rich plasma (“
PRP”
),a plurality of syringes used for one or more of (i) the collection of PRP;
(ii) mixing PRP with said first container of dHACM and/or AMA to form a therapeutic mixture, and (iii) injecting said therapeutic mixture intradermally or subcutaneously into a subject.wherein each of the total amounts of the collected PRP, and the first container of dHACM and/or AMA is an amount effective to promote hair growth of a subject suffering from hair loss.
-
Specification